第二项与强直性脊柱炎相关的RUNX3调控多态性证据
在4230例英国病例中确认rs4265380独立于邻近RUNX3 SNP rs4648889与强直性脊柱炎相关(P=4.7×10⁻⁶),含两SNP的单倍型OR 6.2(95%CI 3.1–13.2,P=1.4×10⁻⁸)。rs4265380所在RUNX3区域显示增强子功能,单核细胞中该位点存在等位基因差异性核蛋白结合,AS患者外周血单个核细胞RUNX3表达低于健康对照(P<0.002)。
要点
- rs4265380与强直性脊柱炎独立相关,条件化于rs4648889后P=4.7×10⁻⁶。
- 含rs4265380与rs4648889的RUNX3单倍型与AS强关联,OR 6.2。
- rs4265380所在区域有增强子功能,单核细胞中呈等位基因差异性蛋白结合。
核心结论
- AS与该RUNX3调控区域的关联涉及至少两个SNP,二者似在不同细胞类型中发挥作用。
- 单核细胞可能是AS的潜在治疗靶点。
研究设计与样本
- 在4230例英国病例中评估单个SNP关联,并通过数据库检索、荧光素酶报告基因实验、电泳迁移率变动分析、染色质免疫沉淀和实时PCR检测转录因子结合、转录调控、染色质修饰、基因表达及基因相互作用。
主要发现
- 确认AS与rs4265380独立关联,条件化于另一邻近AS相关RUNX3 SNP rs4648889后仍稳健(P=4.7×10⁻⁶)。
- 含两个SNP的RUNX3单倍型与AS强关联(OR 6.2;95%CI 3.1至13.2,P=1.4×10⁻⁸)。
- 在英国大型队列中,rs4265380与白细胞计数(包括单核细胞)相关。
- AS外周血单个核细胞RUNX3表达低于健康对照(P<0.002),且不依赖rs4265380基因型。
- 含rs4265380的报告基因构建体荧光素酶活性约增加十倍(P=0.005),提示该RUNX3区域有增强子功能。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To explore the functions of RUNX3 single nucleotide polymorphisms (SNPs) associated with ankylosing spondylitis (AS). METHODS: Individual SNP associations were evaluated in 4230 UK cases. Their effects on transcription factor (TF) binding, transcription regulation, chromatin modifications, gene expression and gene interactions were tested by database interrogation, luciferase reporter assays, electrophoretic mobility gel shifts, chromatin immunoprecipitation and real-time PCR. RESULTS: We confirmed the independent association of AS with rs4265380, which was robust (P=4.7×10-6) to conditioning on another nearby AS-associated RUNX3 SNP (rs4648889). A RUNX3 haplotype incorporating both SNPs was strongly associated with AS (OR 6.2; 95% CI 3.1 to 13.2, P=1.4×10-8). In a large UK cohort, rs4265380 is associated with leucocyte counts (including monocytes). RUNX3 expression is lower in AS peripheral blood mononuclear cells than healthy controls (P<0.002), independent of rs4265380 genotype. Enhancer function for this RUNX3 region was suggested by increased luciferase activity (approximately tenfold; P=0.005) for reporter constructs containing rs4265380. In monocytes, there was differential allelic binding of nuclear protein extracts to a 50 bp DNA probe containing rs4265380 that was strongly augmented by lipopolysaccharide activation. TF binding also included the histone modifier p300. There was enrichment for histone modifications associated with active enhancer elements (H3K27Ac and H3K79Me2) that may be allele dependent. Hi-C database interrogation showed chromosome interactions of RUNX3 bait with the nearby RP4-799D16.1 lincRNA. CONCLUSIONS: The association of AS with this RUNX3 regulatory region involves at least two SNPs apparently operating in different cell types. Monocytes may be potential therapeutic targets in AS.
引用
- Vecellio M, Cortes A, Roberts AR, et al. Evidence for a second ankylosing spondylitis-associated RUNX3 regulatory polymorphism. RMD Open. 2018. PMID: 29531791. doi:10.1136/rmdopen-2017-000628
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。